Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Oftaquix 5mg/ml eye drops 0.3ml unit dose
1103010AGBBACAC
|
Oftaquix | Levofloxacin | Eye | 211 |
|
Tropicamide 1% eye drops
1105000S0AAABAB
|
Tropicamide | Tropicamide | Eye | 196 |
|
Acetazolamide 250mg/5ml oral suspension
1106000B0AABQBQ
|
Acetazolamide | Acetazolamide | Eye | 185 |
|
Oftaquix 5mg/ml eye drops
1103010AGBBAAAA
|
Oftaquix | Levofloxacin | Eye | 172 |
|
Azyter 15mg/g eye drops 0.25g unit dose
1103010AIBBAAAA
|
Azyter | Azithromycin | Eye | 166 |
|
Naphazoline 0.012% eye drops
1104020R0AAAAAA
|
Naphazoline hydrochloride | Naphazoline hydrochloride | Eye | 160 |
|
Nepafenac 3mg/ml eye drops
1108020AFAAABAB
|
Nepafenac | Nepafenac | Eye | 157 |
|
Moxivig 0.5% eye drops
1108020U0BCAAAB
|
Moxivig | Moxifloxacin hydrochloride | Eye | 153 |
|
Relestat 500micrograms/ml eye drops
1104020ACBBAAAA
|
Relestat | Epinastine hydrochloride | Eye | 153 |
|
Nevanac 3mg/ml eye drops
1108020AFBBABAB
|
Nevanac | Nepafenac | Eye | 151 |
|
Dimaz 20mg/ml eye drops
1106000P0BFAAAC
|
Dimaz | Dorzolamide | Eye | 139 |
|
Betoptic 0.25% eye drops suspension 0.25ml unit dose
1106000I0BBACAC
|
Betoptic | Betaxolol | Eye | 134 |
|
Murine irritation & redness relief 0.012% eye drops
1104020R0BBAAAA
|
Murine | Naphazoline hydrochloride | Eye | 131 |
|
Levofloxacin 5mg/ml eye dps 0.5ml ud preservative free
1103010AGAAABAB
|
Levofloxacin (Eye) | Levofloxacin | Eye | 130 |
|
Voltarol Ophtha 0.1% eye drops 0.3ml unit dose
1108020A0BBAAAA
|
Voltarol Ophtha | Diclofenac sodium | Eye | 126 |
|
Glaucopt 20mg/ml / 5mg/ml eye dps 0.166ml ud preserv free
1106000ABBGAAAD
|
Glaucopt | Dorzolamide and timolol | Eye | 105 |
|
Puradex 1mg/ml eye drops
1104010I0BKAAAU
|
Puradex | Dexamethasone | Eye | 102 |
|
Aspire Allergy Relief 2% eye drops
1104020T0BXABAA
|
Aspire (Sodium cromoglicate) | Sodium cromoglicate | Eye | 94 |
|
Brolene 0.1% eye drops
1103010S0BBAAAA
|
Brolene (Eye drops) | Propamidine isetionate | Eye | 94 |
|
Mydrilate 0.5% solution
1105000E0BCAAAB
|
Mydrilate | Cyclopentolate hydrochloride | Eye | 89 |
|
Fluorescein 1% eye drops 0.5ml unit dose preservative free
1108020K0AAAAAA
|
Fluorescein sodium | Fluorescein sodium | Eye | 86 |
|
Cyclopentolate 0.5% eye dps 0.5ml ud preservative free
1105000E0AAAEAE
|
Cyclopentolate hydrochloride | Cyclopentolate hydrochloride | Eye | 81 |
|
Eycrom 2% eye drops
1104020T0BZAAAI
|
Eycrom | Sodium cromoglicate | Eye | 80 |
|
Tropicamide 1% eye drops 0.5ml unit dose preservative free
1105000S0AAADAD
|
Tropicamide | Tropicamide | Eye | 79 |
|
Minims cyclopentolate hydrochloride 1% eye dps 0.5ml ud
1105000E0BBABAF
|
Minims cyclopentolate hydrochloride | Cyclopentolate hydrochloride | Eye | 76 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.